De Wit S et al. |
Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. |
1993 |
Lancet |
pmid:8093299
|
Monteforte JS and Wood CA |
Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8500477
|
Hakkarinen WD |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482929
|
Luger SW |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482930
|
Fraschini F et al. |
Clarithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8222460
|
Neu HC and Chick TW |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. |
1993 |
Chest |
pmid:8222794
|
Kodama R et al. |
[Eradication therapy of Helicobacter pylori in gastroduodenal ulcer and its long-term course]. |
1993 |
Nippon Rinsho |
pmid:8283646
|
Ji B et al. |
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. |
1993 |
J. Infect. Dis. |
pmid:8257487
|
Gevaudan MJ et al. |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex. |
1993 |
J. Antimicrob. Chemother. |
pmid:8392998
|
Wallace RJ et al. |
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. |
1993 |
Ann. Intern. Med. |
pmid:8357113
|
Wettengel R et al. |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8360133
|
Nakashio S et al. |
[Antimicrobial activity of clarithromycin and its effect on bacterial adherence to medical material]. |
1993 |
Jpn J Antibiot |
pmid:8360978
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Graham DY et al. |
Clarithromycin for the eradication of Helicobacter pylori. |
1993 |
J. Clin. Gastroenterol. |
pmid:8331260
|
Esvant H et al. |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. |
1993 |
Presse Med |
pmid:8337221
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
Mazzei T et al. |
Chemistry and mode of action of macrolides. |
1993 |
J. Antimicrob. Chemother. |
pmid:7683018
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|
Ruf B et al. |
Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. |
1992 Sep-Oct |
Infection |
pmid:1428183
|
Friend DR |
Polyacrylate resin microcapsules for taste masking of antibiotics. |
1992 Oct-Dec |
J Microencapsul |
pmid:1403495
|
de Campora E et al. |
Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535578
|
Nilsen OG et al. |
Macrolide pharmacokinetics and dose scheduling of roxithromycin. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535579
|
Hoover WW et al. |
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin. |
1992 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:1533827
|
Chapelsky MC et al. |
Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers. |
1992 Jul-Aug |
Drug Saf |
pmid:1355971
|
Hardy DJ et al. |
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. |
1992 |
Diagn. Microbiol. Infect. Dis. |
pmid:1530914
|
Chu S et al. |
Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial. |
1992 |
J Clin Pharmacol |
pmid:1531484
|
Guay DR and Craft JC |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. |
1992 |
J. Intern. Med. |
pmid:1532615
|
Ruf B et al. |
Failure of clarithromycin in preventing toxoplasmic encephalitis in AIDS patients. |
1992 |
J. Acquir. Immune Defic. Syndr. |
pmid:1532831
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Knothe H |
[Short-term therapy of acute respiratory and ORL infections with Clarithromycin]. |
1992 |
Z Gesamte Inn Med |
pmid:9022402
|
Bale MJ et al. |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin. |
1992 |
J. Clin. Microbiol. |
pmid:1310329
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Bahal N and Nahata MC |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. |
1992 |
Ann Pharmacother |
pmid:1318761
|
Berk SL |
New macrolide antibiotics. |
1992 |
Ann. Intern. Med. |
pmid:1386966
|
Peters DH and Clissold SP |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. |
1992 |
Drugs |
pmid:1379907
|
Biehle J and Cavalieri SJ |
In vitro susceptibility of Mycobacterium kansasii to clarithromycin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416897
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Denny FW |
Current management of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453145
|
Schrock CG |
Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453146
|
Chaisson R |
Clarithromycin is effective against M. avium complex in AIDS. |
1992 |
Am Fam Physician |
pmid:1456199
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Rastogi N et al. |
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482157
|
Derouin F et al. |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482160
|
Takeda H et al. |
[A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa]. |
1992 |
Kansenshogaku Zasshi |
pmid:1363435
|